Conexeu Sciences Inc. — Form SCHEDULE 13D/A
Filed September 15, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 22/100
What the filing says
Jeffrey Nathan Sharpe filed an amended Schedule 13D/A on September 15, 2026, regarding beneficial ownership in Conexeu Sciences Inc. (orthopedic/prosthetic surgical supplies, ~$7.2M in assets). The filing document is present but specific ownership percentages, share counts, dollar amounts, and the nature of the amendment are not disclosed in the metadata provided.
Why this rating
Routine amendment to beneficial ownership filing; no material specifics disclosed. Cannot assess materiality without ownership % or share count relative to company capitalization.
See more from September 15, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.